Terms: = Leukemia AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Treatment
65 results:
1. Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway.
Zhang J; Dai H; Huo L; Burks JK; McGrail DJ; Lin SY
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37907220
[TBL] [Abstract] [Full Text] [Related]
2. Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis.
Ollila TA; Taher R; Moku P; Olszewski AJ
Blood Adv; 2023 Sep; 7(18):5470-5479. PubMed ID: 37459209
[TBL] [Abstract] [Full Text] [Related]
3. Cost-effectiveness analysis of imatinib versus dasatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia when combined with conventional chemotherapy in China.
Chen M; Liu L; Zhang L; Lin Y; Lu X; Yang H; Ni J
BMC Health Serv Res; 2023 Jun; 23(1):652. PubMed ID: 37331932
[TBL] [Abstract] [Full Text] [Related]
4. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Döhner H; Weber D; Krzykalla J; Fiedler W; Kühn MWM; Schroeder T; Mayer K; Lübbert M; Wattad M; Götze K; Fransecky L; Koller E; Wulf G; Schleicher J; Ringhoffer M; Greil R; Hertenstein B; Krauter J; Martens UM; Nachbaur D; Samra MA; Machherndl-Spandl S; Basara N; Leis C; Schrade A; Kapp-Schwoerer S; Cocciardi S; Bullinger L; Thol F; Heuser M; Paschka P; Gaidzik VI; Saadati M; Benner A; Schlenk RF; Döhner K; Ganser A;
Lancet Haematol; 2023 Jul; 10(7):e495-e509. PubMed ID: 37187198
[TBL] [Abstract] [Full Text] [Related]
5. Deep genomic characterization highlights complexities and prognostic markers of pediatric acute myeloid leukemia.
Cheng CK; Yung YL; Chan HY; Leung KT; Chan KYY; Leung AWK; Cheng FWT; Li CK; Wan TSK; Luo X; Pitts HA; Cheung JS; Chan NPH; Ng MHL
Commun Biol; 2023 Mar; 6(1):356. PubMed ID: 37002311
[TBL] [Abstract] [Full Text] [Related]
6. Single-cell profiling of T cells uncovers a tissue-resident memory-like T-cell subset associated with bidirectional prognosis for B-cell acute lymphoblastic leukemia.
Lai W; Wang X; Liu L; Xu L; Mao L; Tan J; Zha X; Zhan H; Lei W; Lan Y; Chen G; Li Y; Luo OJ
Front Immunol; 2022; 13():957436. PubMed ID: 36532049
[TBL] [Abstract] [Full Text] [Related]
7. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
Nguyen TB; Do DN; Nguyen-Thi ML; Hoang-The H; Tran TT; Nguyen-Thanh T
Comput Biol Med; 2022 Oct; 149():105996. PubMed ID: 36049413
[TBL] [Abstract] [Full Text] [Related]
8. Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials.
Kim K; Konopleva M; DiNardo CD; Borthakur G; Loghavi S; Tang G; Daver N; Pemmaraju N; Jabbour E; Rausch CR; Yilmaz M; Sasaki K; Short NJ; Jain N; Brandt M; Pierce S; Garcia-Manero G; Ravandi F; Kantarjian H; Kadia TM
Am J Hematol; 2022 Jul; 97(7):885-894. PubMed ID: 35413152
[TBL] [Abstract] [Full Text] [Related]
9. [Effect of Age on the Time of Neutropenia after Initial Induction Therapy for Patients with Newly Diagnosed Acute Myeloid leukemia].
Jia XY; Chen L; Wei XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):43-48. PubMed ID: 35123602
[TBL] [Abstract] [Full Text] [Related]
10. Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study.
Lynggaard LS; Rank CU; Hansen SN; Gottschalk Højfeldt S; Henriksen LT; Jarvis KB; Ranta S; Niinimäki R; Harila-Saari A; Wolthers BO; Frandsen TL; Heyman M; Schmiegelow K; Albertsen BK
Blood Adv; 2022 Jan; 6(1):138-147. PubMed ID: 34625787
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia.
Wang Y; Zhou W; McReynolds LJ; Katki HA; Griffiths EA; Thota S; Machiela MJ; Yeager M; McCarthy P; Pasquini M; Wang J; Karaesmen E; Rizvi A; Preus L; Tang H; Wang Y; Pooler L; Sheng X; Haiman CA; Van Den Berg D; Spellman SR; Wang T; Kuxhausen M; Chanock SJ; Lee SJ; Hahn TE; Sucheston-Campbell LE; Gadalla SM
Sci Rep; 2021 Jul; 11(1):15004. PubMed ID: 34294836
[TBL] [Abstract] [Full Text] [Related]
12. Expression and prognosis analyses of BUB1, bub1b and BUB3 in human sarcoma.
Long Z; Wu T; Tian Q; Carlson LA; Wang W; Wu G
Aging (Albany NY); 2021 Apr; 13(9):12395-12409. PubMed ID: 33872216
[TBL] [Abstract] [Full Text] [Related]
13.
Ureshino H; Shindo T; Tanaka H; Saji H; Kimura S
Mol Cancer Ther; 2021 Jan; 20(1):142-149. PubMed ID: 33082274
[TBL] [Abstract] [Full Text] [Related]
14. Parental education and cancer mortality in children, adolescents, and young adults: A case-cohort study within the 2011 Italian census cohort.
Alicandro G; Bertuccio P; Sebastiani G; La Vecchia C; Frova L
Cancer; 2020 Nov; 126(21):4753-4760. PubMed ID: 32809229
[TBL] [Abstract] [Full Text] [Related]
15. Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic leukemia/Small Lymphocytic Lymphoma.
Dashputre AA; Gatwood KS; Gatwood J
J Manag Care Spec Pharm; 2020 Feb; 26(2):186-196. PubMed ID: 32011965
[TBL] [Abstract] [Full Text] [Related]
16. A network meta-analysis of maintenance therapy in chronic lymphocytic leukemia.
Lee CH; Chen PH; Lin C; Wang CY; Ho CL
PLoS One; 2020; 15(1):e0226879. PubMed ID: 31995577
[TBL] [Abstract] [Full Text] [Related]
17. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors.
Yoshimitsu M; Fuji S; Utsunomiya A; Nakano N; Ito A; Ito Y; Miyamoto T; Suehiro Y; Kawakita T; Moriuchi Y; Nakamae H; Kanda Y; Ichinohe T; Fukuda T; Atsuta Y; Kato K;
Biol Blood Marrow Transplant; 2020 Apr; 26(4):718-722. PubMed ID: 31821886
[TBL] [Abstract] [Full Text] [Related]
18. Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid leukemia or Acute Lymphoblastic leukemia.
Hijiya N; Zwaan CM; Rizzari C; Foà R; Abbink F; Lancaster D; Landman-Parker J; Millot F; Moppett J; Nelken B; Caterina Putti M; Tian X; Sinclair K; Santanastasio H; Buchbinder A; Kearns P
Clin Cancer Res; 2020 Feb; 26(4):812-820. PubMed ID: 31676669
[TBL] [Abstract] [Full Text] [Related]
19. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.
Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP
Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079
[TBL] [Abstract] [Full Text] [Related]
20. [Comorbidity profile and its impact on reported outcome in Chinese patients with chronic myeloid leukemia in chronic phase receiving tyrosine kinase-inhibitor therapy].
Yu L; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):533-539. PubMed ID: 30122010
[No Abstract] [Full Text] [Related]
[Next]
